News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Athenix Corporation Secures $13 Million In Series C Financing


1/6/2006 10:25:51 AM

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Jan. 6, 2006--Athenix Corp., a leading biotechnology company developing novel products, technologies, and processes for agricultural and chemical applications, announced today it has raised $13 million in growth capital through a Series C venture capital investment. The Series C round was led by new investor Finistere Partners of San Diego, California, with continued strong participation from the entire existing investor group: Intersouth Partners of Durham, North Carolina, Polaris Venture Partners of Waltham, Massachusetts, Boston Millennia Partners of Boston, Massachusetts, Hunt Ventures of Dallas, Texas, and Eastman Ventures, the venture capital arm of Eastman Chemical Company of Kingsport, Tennessee.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES